Global brain and eye research nonprofit BrightFocus Foundation today announced the launch of Let’s Talk Alzheimer’s, a new podcast that brings insightful, actionable conversations about Alzheimer’s disease and brain health to listeners in an accessible, on-demand audio/video format. The podcast features content adapted from BrightFocus’ highly popular Zoom In on Dementia & Alzheimer’s series, which has garnered over 7 million views to date.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611620823/en/
“Families affected by Alzheimer’s disease are seeking clear, trustworthy information they can easily access and understand,” said Stacy Pagos Haller, president and CEO of BrightFocus Foundation. “By adapting our popular, live Zoom In conversations to the podcast format, we’re making these important expert insights available to even more people wherever and whenever they choose to listen.”
The first three episodes, released today, explore eligibility and usage information for the FDA-approved disease-modifying treatments Leqembi and Kisunla (Dr. Armen Moughamian, Sutter Health); how to recognize the earliest signs and symptoms of Alzheimer’s (Dr. Sharon Cohen, University of Toronto); and how modifying certain lifestyle factors have been proven to substantially improve brain health (Dr. Laura Baker, Wake Forest University School of Medicine). Episodes feature internationally recognized Alzheimer’s researchers, physicians, and clinicians; previous guests have included leading researchers from Washington University in St. Louis, Harvard, Mayo Clinic, and Barrow Neurological Institute.
New episodes will be released bi-weekly and available on major podcast platforms, including Spotify, Apple Podcasts, and YouTube.
Let’s Talk Alzheimer’s is hosted by Nancy Keach, senior vice president at BrightFocus Foundation and an award-winning documentary film producer. Episodes cover timely topics such as early diagnosis, treatment options, non-pharmacological interventions, brain health research, active clinical trials, and practical guidance—helping individuals, families, and caregivers make sense of an often overwhelming journey.
“Alzheimer’s research is advancing rapidly, and there is tremendous interest in understanding what these discoveries mean for individuals and families,” said Haller. “This podcast helps translate complex science into engaging, approachable conversations people can listen to anytime.”
To listen and learn more, visit BrightFocus.org/LetsTalkAlzheimers.
BrightFocus thanks the sponsors of Let’s Talk Alzheimer’s for making this program free and accessible to all: Lilly, Biogen, Eisai, and Genentech.
BrightFocus Foundation is a leading provider of free educational resources on Alzheimer’s disease, macular degeneration, and glaucoma, reaching millions of individuals each year through trusted health information and public awareness initiatives.
Among its signature programs are Zoom In on Dementia & Alzheimer’s, Macular Chats, and Glaucoma Chats, presented in partnership with the American Glaucoma Society—free monthly discussions featuring leading scientists, physicians, and vision experts. Through expert-led live webinars, podcasts, articles, fact sheets, and community programs, BrightFocus is dedicated to connecting people with timely, evidence-based information and practical guidance to support brain and vision health.
About BrightFocus Foundation
BrightFocus Foundation is a leading global nonprofit funder of brain and eye research. Since its founding more than 50 years ago, BrightFocus and its flagship programs—Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research—have invested more than $330 million in groundbreaking research grants, driving breakthroughs in treatments, diagnostics, and risk reduction. Learn more and access the latest research news and resources at brightfocus.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260611620823/en/
Media gallery
